FDA Science Board Highlights Shortcomings At CDRH
This article was originally published in The Silver Sheet
CDRH "STRATEGIC PLAN" IMPLEMENTATION will commence in earnest in February after senior center officials meet with an outside management consultant. The Center for Devices and Radiological Health has engaged the services of an organizational development expert to help translate the broad goals of the long-term strategic plan into workable milestones for the center’s various divisions and branches. At the same time, staffers are working to incorporate into the plan recommendations from an external review committee of the FDA Science Board on how to improve the science base of the center. The committee report advocates that CDRH institute major changes in its hiring and training of scientific personnel, use of outside expertise, oversight of combination products and internal assessment
You may also be interested in...
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.